The US Food and Drug Administration changed its guideline on the use of the abortifacient medications Mifeprex, whose generic name is mifepristone, and misoprostol “to terminate a pregnancy 70 days gestation” on Thursday, December 16. The Food and Drug Administration’s new policy emphasized that the drug’s use had previously been approved following a Risk Evaluation and Mitigation Strategy (REMS) undertaken in 2019. The conditions for prescribing the medicine to patients who want to end their pregnancy, according to the 2019 REMS, include being “ordered, prescribed, and delivered by or under the supervision of a healthcare provider who prescribes and meets certain standards.” The FDA stressed that such a prescription is only available from a select group of doctors who are required to use a Prescriber Agreement Form when prescribing Mifeprex and to present patients with the Mifeprex Medication Guide. Patients … Continue reading Deliverable Abortion Medication Legalized.